INVESTIGATOR-INITIATED CLINICAL RESEARCH SUPPORT AGREEMENTClinical Research Support Agreement • January 22nd, 2021 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • California
This Investigator-Initiated Clinical Research Support Agreement (this “Agreement”) is made as of January 13, 2021 (“Effective Date”) by and between City of Hope National Medical Center and City of Hope Medical Foundation (collectively, “Institution”), and Lixte Biotechnology Holdings, Inc., a Delaware corporation (“Corporation”). The Institution and Corporation are each referred to herein as a “Party”, and collectively, as the “Parties”.
